ZURICH, June 20 (Reuters) - Swiss drugmaker Roche
said on Monday its LightMix Modular Zika Virus Assay (CE) is
available in markets accepting the CE mark for patients with
signs and symptoms of the Zika infection where the virus is
known to be present.
Read more
No comments:
Post a Comment